Zhejiang Shouxiangu Pharmaceutical Co Ltd Class A 603896
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥22.42
- Day Range
- ¥23.10–24.66
- 52-Week Range
- ¥18.49–44.00
- Bid/Ask
- ¥24.66 / ¥0.00
- Market Cap
- ¥4.89 Bil
- Volume/Avg
- 6.2 Mil / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 18.81
- Price/Sales
- 5.76
- Dividend Yield (Trailing)
- 1.74%
- Dividend Yield (Forward)
- 1.74%
- Total Yield
- 1.74%
Company Profile
Zhejiang Shouxiangu Pharmaceutical Co Ltd is a Chinese pharmaceutical company.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,143
- Website
- http://www.sxg1909.com
Comparables
Valuation
Metric
|
603896
|
300142
|
688506
|
---|---|---|---|
Price/Earnings (Normalized) | 18.81 | 65.42 | 15.69 |
Price/Book Value | 2.05 | 2.07 | 13.55 |
Price/Sales | 5.76 | 5.81 | 11.26 |
Price/Cash Flow | 12.20 | 18.10 | 15.19 |
Price/Earnings
603896
300142
688506
Financial Strength
Metric
|
603896
|
300142
|
688506
|
---|---|---|---|
Quick Ratio | 3.21 | 2.51 | 2.82 |
Current Ratio | 3.70 | 2.94 | 2.97 |
Interest Coverage | 16.62 | 24.73 | 150.78 |
Quick Ratio
603896
300142
688506
Profitability
Metric
|
603896
|
300142
|
688506
|
---|---|---|---|
Return on Assets (Normalized) | 7.55% | 1.93% | 121.54% |
Return on Equity (Normalized) | 11.00% | 3.16% | 223.68% |
Return on Invested Capital (Normalized) | 7.10% | 2.01% | 155.13% |
Return on Assets
603896
300142
688506
Biotechnology Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Novo Nordisk AS ADR
NVO
| Fwxwplksw | Dgpg | $531.4 Bil | |||
Vertex Pharmaceuticals Inc
VRTX
| Sfnjtwypx | Xkrytj | $119.5 Bil | |||
Regeneron Pharmaceuticals Inc
REGN
| Ffrdqhgpn | Fbxvgy | $114.9 Bil | |||
Alnylam Pharmaceuticals Inc
ALNY
| Jkmjkxtd | Dtfrdpt | $35.3 Bil | |||
argenx SE ADR
ARGX
| Cpjwbbxgm | Vjxlk | $32.0 Bil | |||
BioNTech SE ADR
BNTX
| Tzxskpqz | Syhbw | $28.1 Bil | |||
Moderna Inc
MRNA
| Rdlsygfk | Hdcz | $25.3 Bil | |||
United Therapeutics Corp
UTHR
| Rjkqltdzh | Msd | $16.0 Bil | |||
Biomarin Pharmaceutical Inc
BMRN
| Mjhrylcr | Nwqmhj | $13.4 Bil | |||
Incyte Corp
INCY
| Ngyrlymx | Pwsdnhr | $12.7 Bil |